Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1682
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17241157 | Methods for Attaching Cellular Constituents to a Matrix | Final Rejection | President and Fellows of Harvard College |
| 18470187 | METHODS AND COMPOSITIONS FOR QUANTIFYING IMMUNE CELL DNA | Non-Final OA | GUARDANT HEALTH, INC. |
| 18026287 | HYBRID PROTOCOLS AND BARCODING SCHEMES FOR MULTIPLE SEQUENCING TECHNOLOGIES | Non-Final OA | The Regents of the University of California |
| 17811677 | DETECTING GASTROINTESTINAL NEOPLASMS | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18444227 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 18474060 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 17908809 | FIT-FLARES FOR DETECTION OF INTRACELLULAR ANALYTES IN LIVE CELLS | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18272184 | METHODS AND COMPOSITIONS FOR IDENTIFYING NEUROENDOCRINE PROSTATE CANCER | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18261366 | METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18428058 | SYSTEMS AND METHODS FOR PROCESSING OPTICALLY TAGGED BEADS | Final Rejection | 10X GENOMICS, INC. |
| 17630135 | NUCLEIC ACID CONSTRUCTS AND RELATED METHODS FOR NANOPORE READOUT AND SCALABLE DNA CIRCUIT REPORTING | Final Rejection | University of Washington |
| 18496588 | FACTORS FOR OPTIMIZING IMMUNOTHERAPY | Non-Final OA | Kite Pharma, Inc. |
| 17786397 | METHODS AND COMPOSITIONS FOR MONITORING AND DIAGNOSING HEALTHY AND DISEASE STATES | Final Rejection | Duke University |
| 17783300 | METHOD FOR WHOLE GENOME SEQUENCING OF PICOGRAM QUANTITIES OF DNA | Final Rejection | Oxford University Innovation Limited |
| 18629059 | FLUIDICS SYSTEMS FOR SEQUENTIAL DELIVERY OF REAGENTS | Final Rejection | Life Technologies Corporation |
| 18806109 | Unsupervised Machine Learning Methods | Final Rejection | AMPEL BioSolutions, LLC |
| 17904741 | DYNAMIC FRET-BASED SINGLE-MOLECULE SENSOR FOR ULTRASENSITIVE DETECTION OF NUCLEIC ACIDS | Final Rejection | VIRGINIA COMMONWEALTH UNIVERSITY |
| 18549333 | METHOD FOR DETECTING OR QUANTIFYING PHOTOAGED CELLS, APPLICATION OF SAME, AND METHOD FOR PREPARING PHOTOAGED CELLS | Non-Final OA | Ushio Denki Kabushiki Kaisha |
| 17393609 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Final Rejection | GRAIL, LLC |
| 18253803 | ENCODED ASSAYS | Non-Final OA | PLENO, INC. |
| 18488850 | EPIGENETIC ANALYSIS OF CELL THERAPY AND RELATED METHODS | Final Rejection | Juno Therapeutics, Inc. |
| 18130852 | MARKER FOR RESPONSE TO PD-1/PD-L1 IMMUNOTHERAPY | Non-Final OA | TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. |
| 18019470 | CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS | Non-Final OA | Insight Molecular Diagnostics Inc. |
| 17769173 | REACTIVE AFFINITY PROBE-INTERACTION DISCOVERY PLATFORM | Non-Final OA | Jnana Therapeutics Inc. |
| 18010970 | MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) | Non-Final OA | SEAGEN INC. |
| 18208140 | METHODS FOR DETECTING MUTATIONS IN TARGET NUCLEIC ACIDS USING DUAL PROBES | Non-Final OA | REVVITY HEALTH SCIENCES, INC. |
| 17252619 | SIALIC ACID TRANSPORTER PROTEINS AS BIOMARKERS AND DRUG TARGETS | Final Rejection | Quadram Institute Bioscience |
| 18252634 | PANEL OF MIRNA BIOMARKERS FOR DIAGNOSIS OF OVARIAN CANCER, METHOD FOR IN VITRO DIAGNOSIS OF OVARIAN CANCER, USES OF PANEL OF MIRNA BIOMARKERS FOR IN VITRO DIAGNOSIS OF OVARIAN CANCER AND TEST FOR IN VITRO DIAGNOSIS OF OVARIAN CANCER | Non-Final OA | UNIWERSYTET MEDYCZNY W BIALYMSTOKU |
| 18036215 | Immunotherapy Response Signature | Non-Final OA | Caris MPI, Inc. |
| 18309752 | NUCLEIC ACID SEQUENCING USING EVANESCENT WAVE IMAGING | Non-Final OA | 454 Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy